Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
311
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

746
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
746
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

212
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

748
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
748

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of abdominal fluid bilirubin concentration frequently fails to detect biliary tract rupture in dogs with gallbladder mucocele.

Journal of the American Veterinary Medical Association·2026
Same author

Histoplasma antigen test results are influenced by the urine collection method in dogs.

American journal of veterinary research·2026
Same author

Optimization and validation of a TaqMan real-time PCR for the detection of Heterobilharzia americana in dog feces.

Veterinary parasitology·2026
Same author

<i>Escherichia coli</i>-associated renal malakoplakia in 2 dogs.

Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·2025
Same author

Serum microRNAs 122, 1275, 21, 222, and 181A are not differentially expressed in dogs with idiopathic or copper-associated chronic hepatitis.

American journal of veterinary research·2025
Same author

Age of onset, treatment response, and survival rates in Dutch Kooiker dogs diagnosed with hereditary polymyositis.

Frontiers in veterinary science·2025

Related Experiment Video

Updated: Jan 15, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.9K

Copper-associated Chronic Hepatitis in Dogs.

Elise R den Boer1, Hille Fieten1, Kathleen M Aicher2

  • 1Expertise Centre for Veterinary Genetics, Department of Clinical Sciences, Utrecht University, The Netherlands.

The Veterinary Clinics of North America. Small Animal Practice
|October 11, 2025
PubMed
Summary

Copper-associated hepatitis in dogs stems from genetics and diet. Early diagnosis via liver biopsy and genetic testing aids in preventing liver cirrhosis and managing the disease in predisposed breeds.

Keywords:
ATPase copper transporting alphaATPase copper transporting betaCopperD-penicillamineHepatitisLiver biopsyWilson diseasecopper metabolism domain containing 1

More Related Videos

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury
08:39

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

Published on: September 7, 2018

9.6K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.3K

Related Experiment Videos

Last Updated: Jan 15, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

1.9K
Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury
08:39

Ferric Chloride-induced Canine Carotid Artery Thrombosis: A Large Animal Model of Vascular Injury

Published on: September 7, 2018

9.6K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

12.3K

Area of Science:

  • Veterinary Medicine
  • Canine Hepatology
  • Genetics

Background:

  • Copper-associated hepatitis is a prevalent primary liver disease in dogs.
  • It results from a complex interplay between genetic predisposition and environmental elements, notably dietary copper levels.
  • Specific gene mutations (e.g., ATP7A, ATP7B, COMMD1) contribute to the heritability of this condition.

Purpose of the Study:

  • To elucidate the genetic and environmental factors contributing to copper-associated hepatitis in dogs.
  • To highlight the importance of early diagnostic methods for preventing disease progression.
  • To discuss the role of genetic testing and breeding strategies in managing the condition.

Main Methods:

  • Review of existing literature on canine copper-associated hepatitis.
  • Identification of key genes and mutations associated with the disease.
  • Discussion of diagnostic techniques, including liver biopsy and copper quantification.
  • Analysis of genetic testing and selective breeding as management tools.

Main Results:

  • Certain dog breeds exhibit a higher genetic susceptibility to copper accumulation in the liver.
  • Mutations in specific copper transport genes are linked to the heritability of the disease.
  • Early detection through liver biopsy and copper measurement is crucial for intervention.

Conclusions:

  • Copper-associated hepatitis is a multifactorial disease requiring a comprehensive approach to management.
  • Genetic predisposition plays a significant role in susceptible breeds.
  • Proactive diagnostic and management strategies, including genetic screening, are vital for improving outcomes and preventing cirrhosis.